Search Results - "Asel, C"

Initial serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC by Lang, D., Horner, A., Brehm, E., Akbari, K., Hergan, B., Langer, K., Asel, C., Scala, M., Kaiser, B., Lamprecht, B.

Get full text

159PInitial serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC by Lang, D, Horner, A, Brehm, E, Akbari, K, Hergan, B, Langer, K, Asel, C, Scala, M, Kaiser, B, Lamprecht, B

Get full text

Poster 294 An Exploratory Analysis to Assess Dysphagia and Appropriate Screening Methods in Parkinson Disease by Patel, Sangeeta, Asel, Mackenzie C., Marciniak, Christina M., Patel, Katan, Toledo, Santiago D.

Get full text

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study by Lang, David, Haslinger, Wolfgang, Akbari, Kaveh, Scala, Mario, Hergan, Benedikt, Asel, Christian, Horner, Andreas, Wass, Romana, Brehm, Elmar, Kaiser, Bernhard, Lamprecht, Bernd

“…To evaluate serum tumor markers (STM) as predictive biomarkers in advanced non-small cell lung cancer (NSCLC) treated with chemo-immunotherapy. Patients having…”
Get full text